News Focus
News Focus
Followers 1
Posts 56
Boards Moderated 0
Alias Born 09/02/2016

Re: HappyLibrarian post# 76240

Sunday, 09/25/2016 5:09:26 PM

Sunday, September 25, 2016 5:09:26 PM

Post# of 818431
26 months mPFS in phase 1/2, Northwest Biotherapeutics is to brain cancers what Juno Therapeutics is to leukemia.
Such an impressive number that unless its fake and we believe that the company is fraudulent there is no way to realistically fail primary endpoint in current trial, either that or the fact that they hired cross blinded radiologists to determine progression are the main risks.
We are close to finish line and the stock price finally found a floor, let's find a bit of patience and not forget that any delay means that patients are living longer thanks to this technology.

Best wishes,

Docinvestor
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News